Saturday, November 26, 2022 | Back issues
Courthouse News Service Courthouse News Service

Suspicious Trading

MANHATTAN - The SEC is investigating "highly profitable and suspicious" purchases of call options for Martek Biosciences stock done in the days before Royal DSM announced it would buy all outstanding Martek shares at a 35% premium.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.